In summary, despite the differences depending on phenotypes, the prevalence of asthma was not significantly different in patients with COVID-19, and asthma did not affect the outcomes of COVID-19 in multivariate analysis. Dementia, older age, and initial presentation of skin rash and anemia were independently associated with delayed viral clearance. On the other hand, in patients with headache initially, the viral clearance time was shortened.